| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 132, 646-651, Copyright © 1993 by Endocrine Society
ARTICLES |
HK Ortmeyer, LC Huang, L Zhang, BC Hansen and J Larner
Department of Physiology, University of Maryland School of Medicine, Baltimore 21201.
The acute effects of administration of D-chiroinositol (D-CI), a component of a putative mediator of insulin action, on plasma glucose were examined in low dose streptozotocin-treated rats and normal rats given a glucose load and the effects on plasma glucose and insulin were determined in five obese rhesus monkeys with varying degrees of spontaneous insulin resistance. Single dose intragastric D-CI (10 mg/kg) administered to streptozotocin-treated rats produced a 30-40% decrease in plasma glucose (P < 0.05) at 30-120 min. Single dose intragastric D-CI (2-15 mg/kg) administered to normal rats 2 h before ip glucose produced a 30-50% decrease (P < 0.05) in plasma glucose. D- CI (10 mg/kg) caused a 50% increase (P < 0.05) in glucose disappearance rates in these rats. Myoinositol (10 mg/kg) was without effect. Intravenously administered single dose D-CI (100 mg/kg) increased both the glucose and insulin disappearance rates by 129 +/- 41% (mean +/- SE; P < 0.06) and 89 +/- 39% (P = 0.01), respectively, in all monkeys between 0-30 min compared to control values. D-CI administration, therefore, lowered elevated plasma glucose in streptozotocin-treated hyperglycemic rats, normal rats given a glucose load, and spontaneously insulin-resistant monkeys with or without noninsulin-dependent diabetes mellitus. Intravenous D-CI also lowered plasma insulin in these monkeys.
This article has been cited by other articles:
![]() |
N. R. F. Nascimento, L. M. A. Lessa, M. R. Kerntopf, C. M. Sousa, R. S. Alves, M. G. R. Queiroz, J. Price, D. B. Heimark, J. Larner, X. Du, et al. Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide PNAS, January 3, 2006; 103(1): 218 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cogram, S. Tesh, J. Tesh, A. Wade, G. Allan, N. D.E. Greene, and A. J. Copp D-chiro-inositol is more effective than myo-inositol in preventing folate-resistant mouse neural tube defects Hum. Reprod., September 1, 2002; 17(9): 2451 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Streeter Simple partial purification of d-pinitol from soybean leaves Crop Sci., November 1, 2001; 41(6): 1985 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Nestler, D. J. Jakubowicz, P. Reamer, R. D. Gunn, and G. Allan Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome N. Engl. J. Med., April 29, 1999; 340(17): 1314 - 1320. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |